semaglutide phase 1 Weight loss and muscle loss. The facts. GLP-1 drugs like and tirzepatide produce impressive weight loss — but a consistent and underappreciated finding across trials is that a meaningful proportion of FDA Approves First ORAL GLP-1

Ferrous sulphate triggers ferroptosis in Candida albicans and cures vulvovaginal candidiasis in a mouse model

Save this for your hepatology revision Share it with your co fellows Follow @gastrowiser for board ready gastroenterology Hepcludex (bulevirtide) FDA approved May 2026 first approved treatment for chronic HDV To view or add a comment, sign in Adaptive inhibitor of viral infection - a fantastic study from our secondee, Pedro J

A randomized, placebo-controlled, double-blind, crossover trial was conducted in 42 patients with type 2 diabetes

The intention is also to allow the peptide to come directly in contact with the gut lining

Please register for an account or login here